Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.59 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.59 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.59 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.59 |
| ▸ | REN | P00797 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14454335 | 1.00 | SLC6A2 (0.59) | SLC6A2OPRM1OPRD1OPRK1REN | |
| SCHEMBL29485616 | 1.00 | SLC6A2 (0.59) | SLC6A2OPRM1OPRD1OPRK1REN | |
| SCHEMBL30586507 | 0.93 | SLC6A2 (0.57) | SLC6A2OPRM1OPRD1OPRK1REN | |
| SCHEMBL29710134 | 0.91 | SLC6A2 (0.59) | SLC6A2OPRM1OPRD1OPRK1REN | |
| SCHEMBL12658509 | 0.90 | OPRM1 (0.58) | SLC6A2OPRM1OPRD1OPRK1 | |
| SCHEMBL31377445 | 0.90 | SLC6A2 (0.60) | SLC6A2OPRM1OPRD1OPRK1REN | |
| SCHEMBL31447560 | 0.90 | OPRM1 (0.63) | SLC6A2OPRM1OPRD1OPRK1 | |
| SCHEMBL29440673 | 0.90 | OPRM1 (0.63) | SLC6A2OPRM1OPRD1OPRK1 | |
| SCHEMBL13554943 | 0.90 | PSMB9 (0.54) | SLC6A2OPRM1OPRD1OPRK1REN | |
| SCHEMBL29489418 | 0.90 | SLC6A2 (0.65) | SLC6A2OPRM1OPRD1OPRK1REN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116870184-A | Self-assembled material for improving atherosclerosis as well as preparation method and application thereof | 国家纳米科学中心 | 2023-10-13 | — | — | CN | claimed |
| CN-114920798-A | Self-assembly material constructed in situ at wound part and preparation method and application thereof | 国家纳米科学中心 | 2022-08-19 | — | — | CN | claimed |
| EP-4727565-A1 | ENGINEERED PHAGES AND USES THEREOF | Virginia Tech Intellectual Properties, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20250339554-A1 | COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL | BROAD INST INC (US) | 2025-11-06 | — | — | US | disclosed |
| US-20250223580-A1 | PROGRAMMABLE NUCLEASE-PEPTIDASE COMPOSITIONS | THE BROAD INSTITUTE, INC. | 2025-07-10 | — | — | US | disclosed |
| US-20250171806-A1 | ENGINEERED VIRAL VECTORS WITH ENHANCED PACKAGING CAPACITY AND METHODS OF USING THE SAME | THE BROAD INSTITUTE, INC. (US) | 2025-05-29 | — | — | US | disclosed |
| US-20250129355-A1 | PROGRAMMABLE NUCLEASE-PEPTIDASE COMPOSITIONS | NATIONAL INSTITUTES OF HEALTH | 2025-04-24 | — | — | US | disclosed |
| US-20250073350-A1 | COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2025-03-06 | — | — | US | disclosed |
| US-20250057956-A1 | CELL-TYPE SPECIFIC TARGETING CONTRACTILE INJECTION SYSTEM | THE BROAD INSTITUTE, INC. (US) | 2025-02-20 | — | — | US | disclosed |
| US-20250057984-A1 | CELL-TYPE SPECIFIC MEMBRANE FUSION PROTEINS | THE BROAD INSTITUTE, INC. (US) | 2025-02-20 | — | — | US | disclosed |
| US-20250002541-A1 | ENGINEERED CENTRAL NERVOUS SYSTEM COMPOSITIONS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2025-01-02 | — | — | US | disclosed |
| WO-2023039476-A1 | ENGINEERED MUSCLE AND CENTRAL NERVOUS SYSTEM COMPOSITIONS | THE BROAD INSTITUTE, INC. (US) | 2023-03-16 | — | — | WO | disclosed |
| EP-4143305-A2 | ENGINEERED CENTRAL NERVOUS SYSTEM COMPOSITIONS | The Broad Institute, Inc. (US) | 2023-03-08 | — | — | EP | disclosed |
| CN-111494642-B | Self-assembly material for in-situ construction of artificial extracellular matrix and preparation method and application thereof | 国家纳米科学中心 | 2022-10-14 | — | — | CN | disclosed |
| CN-114920798-A | Self-assembly material constructed in situ at wound part and preparation method and application thereof | 国家纳米科学中心 | 2022-08-19 | — | — | CN | disclosed |
| WO-2022165262-A1 | COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL | THE BROAD INSTITUTE, INC. (US) | 2022-08-04 | — | — | WO | disclosed |
| CN-114805602-A | Polypeptide nano material for binding IgE, and preparation method and application thereof | 国家纳米科学中心 | 2022-07-29 | — | — | CN | disclosed |
| US-20220175848-A1 | METHODS AND COMPOSITIONS FOR CELL THERAPY | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2022-06-09 | — | — | US | disclosed |
| EP-3395372-B1 | GLUTATHIONE-BASED DRUG DELIVERY SYSTEM | ENHANX BIOPHARM INC (TW) | 2022-04-06 | — | — | EP | disclosed |
| CN-110627912-B | Bionic fiber network antibody self-assembly material and preparation method and application thereof | 国家纳米科学中心 | 2022-03-08 | — | — | CN | disclosed |